Patient Access Solutions, Inc. PASO
PASO traded more than twice its ten day average of daily volume on Wednesday, and achieved a higher low for the second consecutive day. .0011 was our previous level of support prior to this week, and now becomes our key resistance point, as the stock struggled a bit to breach that level.
Let’s take a look at the PR they released also, outlining a partnership that will increase the company’s effectiveness in addition to potentially generating three quarters of a million dollars in revenue.
We think that PASO qualifies as an undervalued stock, which is why we continue to hang in there and monitor the situation.
HAUPPAUGE, N.Y., Aug 24, 2011 (BUSINESS WIRE) — Patient Access Solutions, Inc. (Pink Sheets-PASO), a leading provider of information technology solutions for the healthcare industry is pleased to announce it has contracted with Partners in Care, an affiliate of the Visiting Nurse Service of New York. Since 1983, Partners in Care has provided certified home health aides and private-duty nurses who are experienced, compassionate, reliable, and highly attentive to the individuals in their care. Composed of more than 8,100 home health aides, RN’s and LPN’s, Partners in Care is accredited by the Community Health Accreditation Program (CHAP) and licensed by the New York State Department of Health.
The solution, based on PASHealth’s proprietary home healthcare Mobipen digital pen application, will pilot this month with key cluster homes in the Partners in Care organization and expand to other licensed users. Stage I of the implementation plan could have as many as 300 users, generating over $750,000.00 in income to the company. Field workers will be able to process paperwork in their usual work flow, while concurrently being able to digitally transfer the information back to the Partners in Care main office using the robust form capture infrastructure to interface patient data and caregiver digital note application.
United Treatment Centers, Inc. UTRM
Well, we were absolutely on target with our timing when it comes to re-alerting UTRM. We left this play alone for months while it sniffed out a bottom, and we called it to perfection!
Yesterday UTRM stock saw prices as high .0024, which would have represented 140% of intraday gains. The stock managed to close at .0015, holding 50% of its gains on the largest volume day of the past year!
We are so glad that it turned out exactly as we predicted, and do hope that some of you were able to catch the action and benefit.
This significant spike in volume in a strong indicator that many folks are out there accumulating UTRM at its bottom.